Report Detail
Global Human Fibrinogen Market Growth 2019-2024
- RnM2895487 |
- 07 February, 2019 |
- Global |
- 132 Pages |
- LPI(LP Information) |
- Other
Fibrinogen is a protein in the blood plasma that is essential for the coagulation of blood and is converted to fibrin by the action of thrombin in the presence of ionized calcium. Human fibrinogen is a protein which is important for blood clotting (coagulation).
The industry is concentration, the key brand include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical and so on. Among them, CSL Behring and LFB are the leaders.
The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.
Significant and lasting barriers make entry into this market difficult. These barriers include, but are not limited to: (i) product development costs; (ii) capital requirements; (iii) intellectual property rights; (iv) regulatory requirement; and (v) Transitions’ unfair methods of competition.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. Even so, the market is intensely competitive .The study group recommends the new entrants just having money but without technical advantage and upstream and downstream support do not to enter into this field.
According to this study, over the next five years the Human Fibrinogen market will register a 25.1% CAGR in terms of revenue, the global market size will reach US$ 1810 million by 2024, from US$ 470 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Fibrinogen business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Fibrinogen market by product type, application, key manufacturers and key regions and countries.
This study considers the Human Fibrinogen value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Pure Human Fibrinogen
Fibrinogen Concentrate (Human)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Congenital Fibrinogen Deficiency
Surgical Procedures
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
LFB
Shanghai RAAS
Boya
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Fibrinogen consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Human Fibrinogen market by identifying its various subsegments.
Focuses on the key global Human Fibrinogen manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Fibrinogen with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Fibrinogen submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Human Fibrinogen Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human Fibrinogen Consumption 2014-2024
- 2.1.2 Human Fibrinogen Consumption CAGR by Region
- 2.2 Human Fibrinogen Segment by Type
- 2.2.1 Pure Human Fibrinogen
- 2.2.2 Fibrinogen Concentrate (Human)
- 2.3 Human Fibrinogen Consumption by Type
- 2.3.1 Global Human Fibrinogen Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Human Fibrinogen Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Human Fibrinogen Sale Price by Type (2014-2019)
- 2.4 Human Fibrinogen Segment by Application
- 2.4.1 Congenital Fibrinogen Deficiency
- 2.4.2 Surgical Procedures
- 2.5 Human Fibrinogen Consumption by Application
- 2.5.1 Global Human Fibrinogen Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Human Fibrinogen Value and Market Share by Application (2014-2019)
- 2.5.3 Global Human Fibrinogen Sale Price by Application (2014-2019)
3 Global Human Fibrinogen by Players
- 3.1 Global Human Fibrinogen Sales Market Share by Players
- 3.1.1 Global Human Fibrinogen Sales by Players (2017-2019)
- 3.1.2 Global Human Fibrinogen Sales Market Share by Players (2017-2019)
- 3.2 Global Human Fibrinogen Revenue Market Share by Players
- 3.2.1 Global Human Fibrinogen Revenue by Players (2017-2019)
- 3.2.2 Global Human Fibrinogen Revenue Market Share by Players (2017-2019)
- 3.3 Global Human Fibrinogen Sale Price by Players
- 3.4 Global Human Fibrinogen Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Human Fibrinogen Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Human Fibrinogen Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Human Fibrinogen by Regions
- 4.1 Human Fibrinogen by Regions
- 4.1.1 Global Human Fibrinogen Consumption by Regions
- 4.1.2 Global Human Fibrinogen Value by Regions
- 4.2 Americas Human Fibrinogen Consumption Growth
- 4.3 APAC Human Fibrinogen Consumption Growth
- 4.4 Europe Human Fibrinogen Consumption Growth
- 4.5 Middle East & Africa Human Fibrinogen Consumption Growth
5 Americas
- 5.1 Americas Human Fibrinogen Consumption by Countries
- 5.1.1 Americas Human Fibrinogen Consumption by Countries (2014-2019)
- 5.1.2 Americas Human Fibrinogen Value by Countries (2014-2019)
- 5.2 Americas Human Fibrinogen Consumption by Type
- 5.3 Americas Human Fibrinogen Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Human Fibrinogen Consumption by Countries
- 6.1.1 APAC Human Fibrinogen Consumption by Countries (2014-2019)
- 6.1.2 APAC Human Fibrinogen Value by Countries (2014-2019)
- 6.2 APAC Human Fibrinogen Consumption by Type
- 6.3 APAC Human Fibrinogen Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Human Fibrinogen by Countries
- 7.1.1 Europe Human Fibrinogen Consumption by Countries (2014-2019)
- 7.1.2 Europe Human Fibrinogen Value by Countries (2014-2019)
- 7.2 Europe Human Fibrinogen Consumption by Type
- 7.3 Europe Human Fibrinogen Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Human Fibrinogen by Countries
- 8.1.1 Middle East & Africa Human Fibrinogen Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Human Fibrinogen Value by Countries (2014-2019)
- 8.2 Middle East & Africa Human Fibrinogen Consumption by Type
- 8.3 Middle East & Africa Human Fibrinogen Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Human Fibrinogen Distributors
- 10.3 Human Fibrinogen Customer
11 Global Human Fibrinogen Market Forecast
- 11.1 Global Human Fibrinogen Consumption Forecast (2019-2024)
- 11.2 Global Human Fibrinogen Forecast by Regions
- 11.2.1 Global Human Fibrinogen Forecast by Regions (2019-2024)
- 11.2.2 Global Human Fibrinogen Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Human Fibrinogen Forecast by Type
- 11.8 Global Human Fibrinogen Forecast by Application
12 Key Players Analysis
- 12.1 CSL Behring
- 12.1.1 Company Details
- 12.1.2 Human Fibrinogen Product Offered
- 12.1.3 CSL Behring Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CSL Behring News
- 12.2 LFB
- 12.2.1 Company Details
- 12.2.2 Human Fibrinogen Product Offered
- 12.2.3 LFB Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 LFB News
- 12.3 Shanghai RAAS
- 12.3.1 Company Details
- 12.3.2 Human Fibrinogen Product Offered
- 12.3.3 Shanghai RAAS Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Shanghai RAAS News
- 12.4 Boya
- 12.4.1 Company Details
- 12.4.2 Human Fibrinogen Product Offered
- 12.4.3 Boya Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Boya News
- 12.5 Hualan Biological Engineering
- 12.5.1 Company Details
- 12.5.2 Human Fibrinogen Product Offered
- 12.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Hualan Biological Engineering News
- 12.6 Harbin Pacific Biopharmaceutical
- 12.6.1 Company Details
- 12.6.2 Human Fibrinogen Product Offered
- 12.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Harbin Pacific Biopharmaceutical News
- 12.7 Greencross
- 12.7.1 Company Details
- 12.7.2 Human Fibrinogen Product Offered
- 12.7.3 Greencross Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Greencross News
- 12.8 Shanghai XinXing Medical
- 12.8.1 Company Details
- 12.8.2 Human Fibrinogen Product Offered
- 12.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Shanghai XinXing Medical News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Human Fibrinogen . Industry analysis & Market Report on Human Fibrinogen is a syndicated market report, published as Global Human Fibrinogen Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Human Fibrinogen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
